NO980032D0 - Biologisk aktiv blanding omfattende cyklosporin - Google Patents

Biologisk aktiv blanding omfattende cyklosporin

Info

Publication number: NO980032D0
Authority: NO; Norway
Prior art keywords: cyclosporine; biologically active; phase; specific; active mixture
Prior art date: 1995-07-06

Application number

NO980032A

Other languages

English (en)

Other versions

NO980032L (no

Inventor

Kaare Larsson

Helena Ljusberg-Wahren

Original Assignee

Gs Dev Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-07-06

Filing date

1998-01-05

Publication date

1998-01-05

1998-01-05 Application filed by Gs Dev Ab filed Critical Gs Dev Ab

1998-01-05 Publication of NO980032D0 publication Critical patent/NO980032D0/no

1998-03-03 Publication of NO980032L publication Critical patent/NO980032L/no

Links

PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 title abstract 4
108010036949 Cyclosporine Proteins 0.000 title abstract 4
229960001265 ciclosporin Drugs 0.000 title abstract 4
229930182912 cyclosporin Natural products 0.000 title abstract 4
239000000203 mixture Substances 0.000 title abstract 3
LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 abstract 1
229940088623 biologically active substance Drugs 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
229940125721 immunosuppressive agent Drugs 0.000 abstract 1
239000003018 immunosuppressive agent Substances 0.000 abstract 1
239000007788 liquid Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Transplantation (AREA)
Dispersion Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Air-Conditioning For Vehicles (AREA)
Peptides Or Proteins (AREA)

NO980032A 1995-07-06 1998-01-05 Biologisk aktiv blanding omfattende cyklosporin NO980032L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9502472A SE504582C2 (sv)	1995-07-06	1995-07-06	Cyklosporinkomposition baserad på en L2-fas
PCT/SE1996/000893 WO1997002042A1 (en)	1995-07-06	1996-07-02	Biologically active composition comprising cyclosporine

Publications (2)

Publication Number	Publication Date
NO980032D0 true NO980032D0 (no)	1998-01-05
NO980032L NO980032L (no)	1998-03-03

Family

ID=20398887

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO980032A NO980032L (no)	1995-07-06	1998-01-05	Biologisk aktiv blanding omfattende cyklosporin

Country Status (12)

Country	Link
EP (1)	EP0873133B1 (no)
JP (1)	JPH11508592A (no)
AT (1)	ATE213951T1 (no)
AU (1)	AU6374596A (no)
BR (1)	BR9609332A (no)
CA (1)	CA2226219A1 (no)
CZ (1)	CZ1998A3 (no)
DE (2)	DE69619700T2 (no)
ES (1)	ES2123477T3 (no)
NO (1)	NO980032L (no)
SE (1)	SE504582C2 (no)
WO (1)	WO1997002042A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE511313C2 (sv)	1997-01-13	1999-09-06	Gs Dev Ab	Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
JP4761093B2 (ja)	1997-12-10	2011-08-31	シクロスポリンセラポイティクスリミテッド	オメガ−３脂肪酸油を含む医薬組成物
US6979456B1 (en)	1998-04-01	2005-12-27	Jagotec Ag	Anticancer compositions
PL348193A1 (en) *	1998-12-11	2002-05-06	Pharmasolutions	Self-emulsifying compositions for drugs poorly soluble in water
US8460693B2 (en)	2001-11-08	2013-06-11	Atrium Medical Corporation	Intraluminal device with a coating containing synthetic fish oil and a therapeutic agent
US9012506B2 (en)	2004-09-28	2015-04-21	Atrium Medical Corporation	Cross-linked fatty acid-based biomaterials
US9801982B2 (en)	2004-09-28	2017-10-31	Atrium Medical Corporation	Implantable barrier device
US9000040B2 (en)	2004-09-28	2015-04-07	Atrium Medical Corporation	Cross-linked fatty acid-based biomaterials
US8367099B2 (en)	2004-09-28	2013-02-05	Atrium Medical Corporation	Perforated fatty acid films
WO2007011385A2 (en)	2004-09-28	2007-01-25	Atrium Medical Corporation	Heat cured gel and method of making
US8263102B2 (en)	2004-09-28	2012-09-11	Atrium Medical Corporation	Drug delivery coating for use with a stent
US8124127B2 (en)	2005-10-15	2012-02-28	Atrium Medical Corporation	Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
US8312836B2 (en)	2004-09-28	2012-11-20	Atrium Medical Corporation	Method and apparatus for application of a fresh coating on a medical device
US9427423B2 (en)	2009-03-10	2016-08-30	Atrium Medical Corporation	Fatty-acid based particles
US9278161B2 (en)	2005-09-28	2016-03-08	Atrium Medical Corporation	Tissue-separating fatty acid adhesion barrier
US9492596B2 (en)	2006-11-06	2016-11-15	Atrium Medical Corporation	Barrier layer with underlying medical device and one or more reinforcing support structures
WO2008057344A2 (en)	2006-11-06	2008-05-15	Atrium Medical Corporation	Coated surgical mesh
CA2683415C (en)	2007-04-04	2020-12-08	Sigmoid Pharma Limited	An oral pharmaceutical composition
JP5640079B2 (ja)	2009-05-18	2014-12-10	シグモイド・ファーマ・リミテッドＳｉｇｍｏｉｄＰｈａｒｍａＬｉｍｉｔｅｄ	油滴含有組成物
US20110038910A1 (en)	2009-08-11	2011-02-17	Atrium Medical Corporation	Anti-infective antimicrobial-containing biomaterials
BR112012002963A2 (pt)	2009-08-12	2017-10-24	Sigmoid Pharma Ltd	composições imunomoduladoras compreendendo uma matriz de polímero e uma fase oleosa
WO2012009707A2 (en)	2010-07-16	2012-01-19	Atrium Medical Corporation	Composition and methods for altering the rate of hydrolysis of cured oil-based materials
GB201020032D0 (en)	2010-11-25	2011-01-12	Sigmoid Pharma Ltd	Composition
JO3337B1 (ar)	2010-12-13	2019-03-13	Debiopharm Sa	تركيبات صيدلية تشمل أليسبوريفير
US9867880B2 (en)	2012-06-13	2018-01-16	Atrium Medical Corporation	Cured oil-hydrogel biomaterial compositions for controlled drug delivery
GB201304662D0 (en)	2013-03-14	2013-05-01	Sigmoid Pharma Ltd	Compositions
EA036036B1 (ru) *	2014-11-07	2020-09-16	Сигмойд Фарма Лимитед	Композиции, содержащие циклоспорин

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI65914C (fi) *	1978-03-07	1984-08-10	Sandoz Ag	Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
SE457693B (sv) *	1986-07-01	1989-01-23	Drilletten Ab	Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas
GB9113872D0 (en) *	1991-06-27	1991-08-14	Sandoz Ag	Improvements in or relating to organic compounds

1995
- 1995-07-06 SE SE9502472A patent/SE504582C2/sv not_active IP Right Cessation
1996
- 1996-07-02 EP EP96923154A patent/EP0873133B1/en not_active Expired - Lifetime
- 1996-07-02 CZ CZ9819A patent/CZ1998A3/cs unknown
- 1996-07-02 ES ES96923154T patent/ES2123477T3/es not_active Expired - Lifetime
- 1996-07-02 AT AT96923154T patent/ATE213951T1/de not_active IP Right Cessation
- 1996-07-02 BR BR9609332A patent/BR9609332A/pt not_active Application Discontinuation
- 1996-07-02 WO PCT/SE1996/000893 patent/WO1997002042A1/en not_active Ceased
- 1996-07-02 DE DE69619700T patent/DE69619700T2/de not_active Expired - Fee Related
- 1996-07-02 CA CA002226219A patent/CA2226219A1/en not_active Abandoned
- 1996-07-02 AU AU63745/96A patent/AU6374596A/en not_active Abandoned
- 1996-07-02 JP JP9505078A patent/JPH11508592A/ja active Pending
- 1996-07-02 DE DE0873133T patent/DE873133T1/de active Pending
1998
- 1998-01-05 NO NO980032A patent/NO980032L/no unknown

Also Published As

Publication number	Publication date
SE9502472L (sv)	1997-01-07
CA2226219A1 (en)	1997-01-23
DE873133T1 (de)	1999-05-06
BR9609332A (pt)	1999-05-25
DE69619700D1 (de)	2002-04-11
AU6374596A (en)	1997-02-05
NO980032L (no)	1998-03-03
SE9502472D0 (sv)	1995-07-06
ATE213951T1 (de)	2002-03-15
EP0873133B1 (en)	2002-03-06
JPH11508592A (ja)	1999-07-27
ES2123477T3 (es)	2002-08-01
ES2123477T1 (es)	1999-01-16
EP0873133A1 (en)	1998-10-28
CZ1998A3 (cs)	1998-06-17
DE69619700T2 (de)	2002-10-24
WO1997002042A1 (en)	1997-01-23
SE504582C2 (sv)	1997-03-10

Publication	Publication Date	Title
NO980032D0 (no)	1998-01-05	Biologisk aktiv blanding omfattende cyklosporin
GB2305122B (en)	1999-06-16	Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
NO20005431D0 (no)	2000-10-27	Gelérbare farmasøytiske preparater
ATE421318T1 (de)	2009-02-15	Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben
DK0580817T3 (da)	1996-08-05	Farmaceutisk præparat og fremgangsmåde til fremstilling deraf
DK312583A (da)	1984-01-08	Kortikoidholdigt praeparat til topisk applikation
IE873213L (en)	1988-05-27	Galenical Formulation
UA27801C2 (uk)	2000-10-16	Спосіб одержання сферул одного чи декількох харчових або медикаментозних активних начал
NO175240C (no)	1998-02-10	Fremgangsmåte for fremstilling av et langsomt frigivende farmasöytisk preparat som omfatter sekundære granuler
KR860000865A (ko)	1986-02-20	약제 제형의 제조방법
NO965244D0 (no)	1996-12-09	Farmasöytisk preparat inneholdende et hydrofobt aktivt stoff og et brusesystem, og fremgangsmåte til fremstilling derav
FR2553409B1 (fr)	1986-04-18	Nouveaux benzenesulfonyl-lactames, leur procede de preparation et leur application comme substance active de compositions pharmaceutiques
YU49113B (sh)	2004-03-12	Postupak za dobijanje klavulanat soli
GB2303791A (en)	1997-03-05	Method of preparing a predetermined active agent stock solution for liposomal microencapsulation of active agents for agricultural uses
WO1997000671A3 (de)	1997-02-13	Zusammensetzung zur herstellung feindisperser systeme und verfahren zu ihrer herstellung
IE36563L (en)	1973-01-23	Triazolo benzodiazepines
JPS5558203A (en)	1980-04-30	Hard polyvinyl alcohol gel and its preparation
EP0202653A3 (en)	1988-12-14	Dispersible tablet and granulation product and method of formulation of same
ES463092A1 (es)	1978-12-01	Procedimiento de obtencion de los compuestos 8-(1h-tetrazol-5-il)-11h pirido (2,1-b) quinazolin-11-onas, y las sales farmaceuticamente aceptables de acidos y bases de los mis- mos.
ES8504665A1 (es)	1985-05-16	Metodo de preparar derivados de p-acilaminofenol
JPS5354866A (en)	1978-05-18	Method of treating sewege
JPS5659707A (en)	1981-05-23	Lasting antibiotic pharmaceutical and its preparation
FR2449450A1 (fr)	1980-09-19	Nouvelles compositions pharmaceutiques utilisables pour le traitement de l'hypertension
JPS5257390A (en)	1977-05-11	Immobilized enzyme and method of preparing the same
JPS5557510A (en)	1980-04-28	Preparation of improved oil foundation